Practically, reducing insulin demand and lowering hyperglycemia and hyperlipidemia, known as the therapy of ‘resting’ β-cells, have been shown to be effective means of restoring insulin secretion function (Marshak et al., 1999; Boland et al., 2019). The gene discussed is INS; the disease is Hyperglycemia.